NCT02036255View on ClinicalTrials.gov

Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2017

Study Completion Date

May 31, 2018

Conditions

PatencyInfection

Interventions

DRUG

Taurolidine Urokinase

DRUG

Taurolidine Heparin

Trial Locations (9)

1050

Ixelles Hospital, Ixelles-Elsene

Ixelles Hospital, Brussels

1070

Bracops Hospital, Anderlecht

1090

Brugman Hospital, Jette

Universitair Ziekenhuis Brussel, Jette

7500

CHWAPI, Tournai

Unknown

CHU Charleroi, Charleroi

UZ Antwerpen, Antwerp

Ghent Hospital, Ghent

All Listed Sponsors

lead

Universitair Ziekenhuis Brussel

OTHER

NCT02036255 - Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase | Biotech Hunter | Biotech Hunter